|
|
| | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile Basic information |
| Product Name: | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | | Synonyms: | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;9-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;9-BROMO-8-HYDROXY-6,6-DIMETHYL-11-OXO -6,11-DIHYDRO-5H-BENZO[B]CARBAZOLE-3-CARBONITRILE _1256579-06-2;5H-Benzo[b]carbazole-3-carbonitrile, 9-bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-;9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[...;Aletinib Impurity 4 | | CAS: | 1256579-06-2 | | MF: | C19H13BrN2O2 | | MW: | 381.22 | | EINECS: | | | Product Categories: | | | Mol File: | 1256579-06-2.mol | ![9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile Structure](CAS/20150408/GIF/1256579-06-2.gif) |
| | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile Chemical Properties |
| InChI | InChI=1S/C19H13BrN2O2/c1-19(2)12-7-15(23)13(20)6-11(12)17(24)16-10-4-3-9(8-21)5-14(10)22-18(16)19/h3-7,22-23H,1-2H3 | | InChIKey | FTLQDYMGJVZZLI-UHFFFAOYSA-N | | SMILES | N1C2=C(C=CC(C#N)=C2)C2=C1C(C)(C)C1=CC(O)=C(Br)C=C1C2=O |
| | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile Usage And Synthesis |
| Uses | 9-Bromo-6,11-dihydro-8-hydroxy-6,6-dimethyl-11-oxo-5H-benzo[b]carbazole-3-carbonitrile is an intermediate of Alectinib (C183360), a highly selective and potent anaplastic lymphoma kinase (ALK) inhibitor capable of blocking the resistant gatekeeper mutant, which results in reduced cell growth. |
| | 9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile Preparation Products And Raw materials |
|